Soligenix Inc. (SNGX)
NASDAQ HEALTHCAREMoving Averages
SMA 200
$1.59
Price below
Company Profile
Soligenix, Inc., an advanced stage biopharmaceutical company, focuses on developing and marketing products to treat rare diseases in the United States. The company is headquartered in Princeton, New Jersey.
Sector
HEALTHCARE
Industry
BIOTECHNOLOGY
Market Cap
$6.02M
P/E Ratio
None
EPS
$-1.45
Beta
1.315
Dividend Yield
0.00%
52-Week High
$6.23
52-Week Low
$0.28
Similar stocks in BIOTECHNOLOGY
BNTX
BioNTech SE
RSI 44.0
VRTX
Vertex Pharmaceuticals Inc
RSI 50.0
CRSP
CRISPR Therapeutics AG
RSI 55.0
MRNA
Moderna Inc
RSI 41.0
VKTX
Viking Therapeutics Inc
RSI 48.0
SRPT
Sarepta Therapeutics Inc
RSI 42.0
EDIT
Editas Medicine Inc
RSI 59.0
IOVA
Iovance Biotherapeutics Inc
RSI 54.0
NVAX
Novavax Inc
RSI 60.0
DNA
Ginkgo Bioworks Holdings Inc - Class A
RSI 58.0
Data last updated: May 16, 2026 at 2:09 AM EDT
Track SNGX for free
Get e-mail RSI alerts when Soligenix Inc. enters oversold or overbought territory. Free forever.
Add Alert